SCHEMBL1898084

SCHEMBL1898084

Cc1nc(N)nc2nc(S)[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.41
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1766004 0.79 PDPK1 (0.44)
SCHEMBL1290911 0.79 NUDT1 (0.61) NUDT1KDM4EALDH1A1LMNACCNA2
SCHEMBL6424961 0.79 PNP (0.48) NUDT1KDM4EALDH1A1LMNACCNA2
SCHEMBL94823 0.76 NUDT1 (0.33) NUDT1
SCHEMBL7674659 0.72 CYP1A2 (0.35)
SCHEMBL28290898 0.72 NPY5R (0.36) NUDT1
SCHEMBL28751539 0.72 NUDT1 (0.38) NUDT1CCNA2CDK2
SCHEMBL887209 0.71 CYP1A2 (0.41) CDK2
SCHEMBL6360434 0.68 NUDT1 (0.36) NUDT1CDK2
SCHEMBL8216346 0.68 NUDT1 (0.58) NUDT1ALDH1A1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101217999-A Personal care compositions and methods for the beautification of mammalian skin and hair PROCTER & GAMBLE (US) 2008-07-09 CN claimed
EP-1901817-A2 PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR The Procter and Gamble Company (US) 2008-03-26 EP claimed
WO-2007007255-A2 PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR THE PROCTER & GAMBLE COMPANY (US) 2007-01-18 WO claimed
US-20070009474-A1 Personal care compositions and methods for the beautification of mammalian skin and hair THE PROCTER & GAMBLE COMPANY 2007-01-11 US claimed
EP-2498772-B1 COMPOSITION AND METHODS FOR IMPROVING SKIN APPEARANCE SYTHEON LTD (US) 2025-07-30 EP disclosed
CN-113302207-B Antibodies to CD38 and ICAM1 and uses thereof 维尔托索宾科公司 2025-05-13 CN disclosed
CN-108129652-B Polyethylene glycol lysine maleimide thioguanine conjugate 湖南华腾制药有限公司 2020-04-07 CN disclosed
CN-102396113-B Circuit connecting material, film-like circuit connecting material using the circuit connecting material, structure for connecting circuit member, and method for connecting circuit member HITACHI CHEMICAL CO LTD 2014-09-24 CN disclosed
CN-102396038-B Anisotropic conductive particles HITACHI CHEMICAL CO LTD 2014-03-12 CN disclosed
US-8496917-B2 Compositions and methods for improving skin appearance SYTHEON LTD (US) 2013-07-30 US disclosed
US-20130183257-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN APPEARANCE SYTHEON LTD. (US) 2013-07-18 US disclosed
EP-2498772-A2 COMPOSITION AND METHODS FOR IMPROVING SKIN APPEARANCE Sytheon Ltd. (US) 2012-09-19 EP disclosed
CN-101137768-A Surface treatment method for copper and copper HITACHI CHEMICAL CO LTD (JP) 2008-03-05 CN disclosed
WO-2007007255-A3 PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR PROCTER & GAMBLE (US) 2007-03-29 WO disclosed
WO-2007007255-A2 PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR THE PROCTER & GAMBLE COMPANY (US) 2007-01-18 WO disclosed
WO-2007007255-A2 PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR THE PROCTER & GAMBLE COMPANY (US) 2007-01-18 WO disclosed
US-20070009474-A1 Personal care compositions and methods for the beautification of mammalian skin and hair THE PROCTER & GAMBLE COMPANY 2007-01-11 US disclosed
US-20070009474-A1 Personal care compositions and methods for the beautification of mammalian skin and hair THE PROCTER & GAMBLE COMPANY 2007-01-11 US disclosed
CN-1867576-A Alpha-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2' -deoxy-2' -fluoro-beta-D-arabinonucleosid e YAMASA CORP (JP) 2006-11-22 CN disclosed
CN-1361827-A Process for producing nucleoside compound MITSUI CHEMICALS INC (JP) 2002-07-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130183257-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN APPEARANCE CUTA, C5, C1S NUDT1 3981/4885KDM4E 1649/4885ALDH1A1 2787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.